The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
GaviLyte-H and Bisacodyl
Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet · Kit · Oral · Lupin Pharmaceuticals, Inc.
NDC 43386-0071-83 · 1 KIT in 1 KIT * 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK * 2 L in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Novel Laboratories, Inc.United Statesanalysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA202217
- TE code
- —
- Approval date
- Aug 20, 2014
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet (Kit)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Lupin Pharmaceuticals, Inc. | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "GaviLyte-H and Bisacodyl — NDC 43386-0071-83," retrieved September 3, 2026, https://drugdashboards.com/drug/43386007183.
Free to cite with attribution — see how the data is put together.